Ana Martins wrote a new post 1 week, 3 days ago
The POLAR Promise: Groundbreaking Survival Gains for Targeted Pancreatic Cancer Patients in Phase II Trial
Phase II trial of Pembrolizumab Immunotherapy and Olaparib (POLAR) trial: new data presented at the European Society for Medical Oncology (ESMO) 2024 […]-
Ana Martins wrote a new post 4 months, 2 weeks ago
GUIDE.MRD Consortium Holds Productive 2nd Annual General Assembly in Hamburg
The GUIDE.MRD consortium partners met for the 2nd annual general assembly, which was hosted by the coordinating institution (University Hamburg […] -
Ana Martins wrote a new post 4 months, 2 weeks ago
EMA Approves New First-line Treatment Option for Metastatic Pancreatic Cancer
Irinotecan hydrochloride trihydrate (Onivyde pegylated liposomal) was approved in March 2024 by the European Medicines Agency […] -
Ana Martins wrote a new post 6 months, 2 weeks ago
"DIGESTIVE CANCER – CURRENT AND FUTURE APPROACHES FOCUSED ON PREVENTION" Highlights the Importance of Awareness and Prevention
On 26 February, the Main Auditorium of the Portuguese Oncology Institute of Porto (IPO Porto) was the stage for the event “Digestive Cancer – […] -
Ana Martins wrote a new post 7 months, 3 weeks ago
Gemcitabine Plus Paclitaxel vs Gemcitabine Alone after FOLFIRINOX in Metastatic Pancreatic Cancer
GEMPAX was an open-label (both researchers and patients know which treatment is being administered), randomised (randomly assigns participants i […] -
Ana Martins changed their profile picture 11 months, 1 week ago
-
Ana Martins wrote a new post 11 months, 1 week ago
F2F Consortium Meeting in Madrid
The GUIDE.MRD (Guiding multi-modal therapies against MRD by liquid biopsies) consortium partners met for the first face-to-face annual meeting […] -
Ana Martins wrote a new post 1 year, 2 months ago
Predictive Values of Blood-based RNA Signature for the FOLFIRINOX/FOLFOX Response in Advanced Pancreatic Cancer
Presently, no widely recognised or established biomarkers are specifically designed to predict the effectiveness of FOLFIRINOX/FOLFOX […] -
Ana Martins wrote a new post 1 year, 2 months ago
DIPLOMA Trial: Minimally Invasive Surgery is an Effective Treatment Option for Early-Stage Pancreatic Cancer
A notable study, DIPLOMA, led by Abu Hilal, M.D., Ph.D., of the Istituto Ospedaliero Fondazione Poliambulanza in Brescia, Italy, involved a large […] -
Ana Martins wrote a new post 1 year, 2 months ago
Personalized mRNA Pancreatic Cancer Vaccine Shows Promising Results in Small Trial
Messenger RNA (mRNA) vaccines – famous for preventing symptomatic infection of COVID-19—are starting to show some promise against pancreatic c […]
